key: cord-0872154-n8wecthp
authors: Isikbay, Masis; Hope, Michael D.; Raptis, Constantine A.; Shah, Amar; Bierhals, Andrew J.; Bhalla, Sanjeev; Hammer, Mark M.; Kligerman, Seth J.; Jeudy, Jean; Filev, Peter D.; Henry, Travis S.
title: CT on the Diamond Princess: What Might This Tell Us About Sensitivity for COVID-19?
date: 2020-04-20
journal: Radiol Cardiothorac Imaging
DOI: 10.1148/ryct.2020200155
sha: 5c3fa2e9a318c1be6594b0e2e0ebc4f197f06dae
doc_id: 872154
cord_uid: n8wecthp

nan

We read with interest the recent paper by Inui et al describing chest CT findings in patients with COVID-19 infection aboard the "Diamond Princess" cruise ship (1) . The study consisted of 104 patients with PCR-confirmed COVID-19, who also underwent chest CT. The authors focused on characterizing findings in symptomatic versus asymptomatic patients, concluding that there was a high incidence of subclinical changes on CT scans performed on confirmed COVID-19 patients.

However, we believe the authors overlooked an important conclusion that has implications regarding the sensitivity of CT for the diagnosis of COVID-19. In this cohort of RT-PCR-confirmed patients, 39% had no lung opacities, including 21% of symptomatic patients. This means chest CT had only a 61% sensitivity for detecting any lung abnormalities in COVID-19, and a 20% false-negative rate in symptomatic patients.

These data starkly contrast with widely cited literature reporting CT sensitivity for COVID-19 as high as 97%-98% (2,3). The differences in sensitivities between studies likely reflects the unique cohorts studied; we believe that the earlier literature from China was likely biased toward symptomatic patients imaged in later stages of disease. The current findings are more in line with Bernheim et al, who found that 56% of CTs were normal in the first 2 days after symptom onset (4).

The article by Inui et al reinforces a limited diagnostic role for CT. Even when RT-PCR may be in limited supply, we endorse the consensus statements provided by the ACR and other societies (5) , especially in populations where the prevalence of disease is low. This determination is based on a significant percentage of normal CT scans in RT-PCR confirmed COVID-19 patients (asymptomatic and symptomatic), and the lack of specific imaging findings that are definitive for COVID-19 pneumonia. RT-PCR remains the reference standard for diagnosis; it is a molecular test that identifies a finding not present in normals or those without the disease. This is of particular importance given the logistical and safety issues of imaging suspected or known COVID-19 patients with CT, and the persistent need to isolate patients with clinical suspicion, even if imaging findings are negative or inconclusive. potential selection bias (2) . Therefore, we believe our data to be robust, consistent with a clinical study (3) . We agree that the low sensitivity precludes use of CT for the initial screening especially in the areas of low prevalence.

Second, from the management perspective, we have to be sensitive to the cost of CT for COVID-19 cases while preventing nosocomial infection. These costs include personal and airborne precautions, and the time and special separation needed to conduct the radiologic examinations.

In our hospital, we adopted a CT-first strategy with a 6-row CT scanner dedicated for COVID-19

cases. The CT scanner room was side-by-side with the emergency room. Patients with positive real-time reverse transcription polymerase chain reaction underwent CT and were admitted to the isolation ward to minimize contact with other persons. Accordingly, initial screening with chest radiography was not done, and so its value as the initial screening measure could not be addressed. Taking these costs and risks of nosocomial infection into account, we agree with expert opinions that chest CT be reserved for cases in which a likely impact on clinical decision making can be anticipated (4) (5) . Furthermore, the cost and risk of CT examinations should be reconsidered in the context of the potential screening value of chest radiography.

Chest CT Findings in Cases from the Cruise Ship "Diamond Princess" with Coronavirus Disease 2019 (COVID-19). Radiol Cardiothorac Imaging

Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases

Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR

Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection

ACR-Position-Statements/Recommendations-for-Chest-Radiography-and-CT-for-Suspected-COVID19-Infection

Chest CT Findings in Cases from the Cruise Ship "Diamond Princess" with Coronavirus Disease 2019 (COVID-19). Radiology: Cardiothoracic Imaging

Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases

Clinical Characteristics of Coronavirus Disease 2019 in China

Radiology Department Preparedness for COVID-19: Radiology Scientific Expert Panel

ACR Recommendations for the use of Chest Radiography and Computed Tomography (CT) for Suspected COVID-19 Infection

Statements/Recommendations-for-Chest-Radiography-and-CT-for-Suspected-COVID19-Infection